Literature DB >> 23331963

Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.

Haendel G N O Busatti1, Ricardo J Alves, Karla G Santana-Anjos, Frederico F Gil, Marcia C Cury, Marcos A Vannier-Santos, Maria A Gomes.   

Abstract

The chemotherapeutic agents used for the treatment of giardiasis are often associated with adverse side effects and are refractory cases, due to the development of resistant parasites. Therefore the search for new drugs is required. We have previously reported the giardicidal effects of metronidazole (MTZ) and its analogues (MTZ-Ms, MTZ-Br, MTZ-N(3), and MTZ-I) on the trophozoites of Giardia lamblia. Now we evaluated the activity of some giardicidal MTZ analogues in experimental infections in gerbils and its effects on the morphology and ultrastructural organization of Giardia. The giardicidal activity in experimental infections showed ED(50) values significantly lower for MTZ-I and MTZ-Br when compared to MTZ. Transmission electron microscopy was employed to approach the mechanism(s) of action of MTZ analogues upon the protozoan. MTZ analogues were more active than MTZ in changing significantly the morphology and ultrastructure of the parasite. The analogues affected parasite cell vesicle trafficking, autophagy, and triggered differentiation into cysts. These results coupled with the excellent giardicidal activity and lower toxicity demonstrate that these nitroimidazole derivates may be important therapeutic alternatives for combating giardiasis. In addition, our results suggest a therapeutic advantage in obtaining synthetic metronidazole analogues for screening of activities against other infectious agents.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23331963     DOI: 10.1016/j.diagmicrobio.2012.11.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Assessment of therapeutic potential of Allium sativum and Zingiber officinale commercial supplements in experimental giardiasis models.

Authors:  Fatma M A Eissa; Iman R Abdel-Shafi; Shaimaa H El-Sayed; Mohamed S Negm; Jumana A Ahmed
Journal:  J Parasit Dis       Date:  2022-04-25

2.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

Review 3.  Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa.

Authors:  Yasmin Pedra-Rezende; Isabela S Macedo; Victor Midlej; Rafael M Mariante; Rubem F S Menna-Barreto
Journal:  Front Microbiol       Date:  2022-03-29       Impact factor: 5.640

4.  Trans-spliced heat shock protein 90 modulates encystation in Giardia lamblia.

Authors:  Rishi Kumar Nageshan; Nainita Roy; Shatakshi Ranade; Utpal Tatu
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

Review 5.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

Review 6.  Parasitic diarrheal disease: drug development and targets.

Authors:  Amir Azam; Mudasir N Peerzada; Kamal Ahmad
Journal:  Front Microbiol       Date:  2015-10-27       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.